BRISTOL-MYERS SQUIBB CO (BMY)
US1101221083 - Common Stock
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Monday.
These S&P500 stocks are moving in today's session
Noteworthy Monday Option Activity: BMY, PWR, MCD
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
These S&P500 stocks have an unusual volume in today's session
These S&P500 stocks are moving in today's session
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
S&P 500 Movers: MPWR, BMY
Bristol Myers Rockets 12% After AbbVie's Schizophrenia Drug Fails
AbbVie stock also tumbled after its experimental schizophrenia treatment failed in two Phase 2 studies.
Bristol Myers Squibb to Participate in Upcoming Investor Conferences
Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
On Friday, Bristol Myers Squibb stock earned an upgrade to its Relative Strength (RS) Rating, from 62 to 79.
Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review
The major indexes declined, but haven't fallen apart.
Notable Thursday Option Activity: LPLA, INSM, BMY
December 13th Options Now Available For Bristol Myers Squibb (BMY)
Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript
BMY earnings call for the period ending September 30, 2024.
See Which Of The Latest 13F Filers Holds Bristol Myers Squibb
Bristol Myers Earnings Top Q3 Estimates; Pharma Giant Raises Guidance
The pharma giant has been trading tightly in recent weeks.
Bristol Raises Guidance on Strong Demand for Eliquis, New Drugs
Bristol Myers Squibb Co. raised its 2024 earnings guidance after reporting better-than-expected revenue and profit, fueled by demand for the blood-thinner Eliquis and several newer treatments.
Bristol Myers Squibb Reports Third Quarter Financial Results for 2024
Bristol Myers Squibb to Present New Clinical and Health Economics and Outcomes Research Data at Psych Congress 2024